Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.33 USD | -1.11% | -8.26% | -21.50% |
Financials (USD)
Sales 2024 * | 30.26M | Sales 2025 * | 42.77M | Capitalization | 144M |
---|---|---|---|---|---|
Net income 2024 * | -20M | Net income 2025 * | -19M | EV / Sales 2024 * | 4.77 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.37 x |
P/E ratio 2024 * |
-7.04
x | P/E ratio 2025 * |
-7.54
x | Employees | 107 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.4% |
Latest transcript on ClearPoint Neuro, Inc.
1 day | -1.11% | ||
1 week | -8.26% | ||
Current month | -21.62% | ||
1 month | -23.64% | ||
3 months | -29.03% | ||
6 months | +9.90% | ||
Current year | -21.50% |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Burnett
CEO | Chief Executive Officer | 47 | 17-11-06 |
Director of Finance/CFO | 39 | 20-09-28 | |
Mazin Sabra
COO | Chief Operating Officer | 44 | 22-10-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
B. Johnson
BRD | Director/Board Member | 72 | 19-08-31 |
Lynnette Fallon
BRD | Director/Board Member | 64 | 21-07-14 |
R. Fletcher
CHM | Chairman | 78 | 17-05-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +1.25% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 5.33 | -1.11% | 129,081 |
24-04-18 | 5.39 | -2.53% | 86,697 |
24-04-17 | 5.53 | -0.90% | 137,965 |
24-04-16 | 5.58 | -0.53% | 113,266 |
24-04-15 | 5.61 | -3.44% | 304,738 |
Delayed Quote Nasdaq, April 19, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.50% | 144M | |
+2.64% | 208B | |
+1.80% | 174B | |
+8.59% | 130B | |
+16.47% | 98.97B | |
-3.42% | 60.46B | |
+12.71% | 51.73B | |
-6.61% | 45.33B | |
-4.53% | 38.9B | |
+9.27% | 38.56B |
- Stock Market
- Equities
- CLPT Stock